Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Nov 09, 2020 1:08pm
151 Views
Post# 31863748

3 Long Island malls to get pop-up COVID-19 test labs

3 Long Island malls to get pop-up COVID-19 test labs

Holiday shoppers will be able to get COVID-19 tests as they buy presents with the opening of pop-up labs at Long Island's Roosevelt Field mall, Smith Haven Mall and Walt Whitman Shops.

Eight-foot by 20-foot collection sites are scheduled to open in the mall parking lots by the end of November, marking the latest step in taking COVID-19 testing beyond hospitals and clinics.

The walk-up collection sites will offer two kinds of tests for active cases of COVID-19 and one antibody test to detect if someone contracted the disease previously and has since developed antibodies.

Tim Shelburn, chief operating officer of the unit of Toronto-based QuestCap Inc., which runs the testing sites, said the facilities will be staffed by three to six laboratory assistants.

"The key to this whole pandemic is testing" he said. "All the malls are expecting heavy holiday traffic."

Shelburn said that the company's contract calls for it to keep the facilities in place for the duration of the pandemic, though they could be repurposed as vaccination sites once those medicines are available.

Roosevelt Field in Garden City, Smith Haven in Lake Grove and Walt Whitman in Huntington Station are operated by Simon Property Group Inc., which has contracted with QuestCap to set up the testing facilities at more than 160 other locations nationwide.
 

Shelburn said the facilities would accept Medicare, Medicaid and all major insurance policies.

A rapid antibody test returning results the next day will cost $59 and the widely used PCR test for active coronavirus in which a swab is inserted deep into the nose will cost $179.

Antigen tests, also designed to detect the active virus, will cost $99.

Earlier this month the Food and Drug Administration cautioned health care providers to beware of false positives with antigen tests when users do not adhere to instructions.

https://www.newsday.com/business/coronavirus/covid-test-roosevelt-whitman-haven-mall-1.50059238

<< Previous
Bullboard Posts
Next >>